AI News about molecular diagnostics

Abbott completes acquisition of Exact Sciences

Abbott Completes $2.8B Exact Sciences Acquisition Abbott has finalized its acquisition of Exact Sciences, strengthening its position in cancer screening and diagnostics. The deal advances Abbott's strategy to expand accessible healthcare solutions and empower patients with greater health control. This consolidation positions Abbott as a major player in the fast-growing molecular diagnostics market.